---
layout: startup_page
title: "Lutris Pharma"
id: "lutrispharma.com"
permalink: "/lutrispharmalutrispharma.com04022025/"
website: "https://www.lutris-pharma.com/"
funding_round: "Series A"
funding_amount: "$30M"
investors: "Columbus Venture Partners, Pontifax Venture Capital, Peregrine Ventures, aMoon Fund"
about: "Lutris Pharma is a clinical-stage biopharmaceutical company developing topical therapies to mitigate the cutaneous toxicity of anti-cancer treatments. Their lead asset, LUT014, aims to reduce EGFRi-induced acneiform rash, a common side effect that often leads to treatment discontinuation. This improves both patient quality of life and the efficacy of cancer therapies."
markets: "Biopharmaceuticals, Oncology, Dermatology, Biotechnology, Drug Discovery"
hq: "Tel Aviv, , Israel"
founded_year: "2015"
linkedin: "https://www.linkedin.com/company/lutris-phama"
twitter: ""
instagram: ""
facebook: ""
crunchbase: "https://www.crunchbase.com/organization/lutris-pharma"
pitchbook: "https://pitchbook.com/profiles/company/168642-55"

# SEO Optimization
meta_title: "Lutris Pharma - Series A Funding ($30M)"
meta_description: "Lutris Pharma, Lutris Pharma is a clinical-stage biopharmaceutical company developing topical therapies to mitigate the cutaneous toxicity of anti-cancer treatments...."
meta_keywords: "Lutris Pharma, Biopharmaceuticals, Oncology, Dermatology, Biotechnology, Drug Discovery, Series A funding"
canonical_url: "https://pkprojectstartups.github.io/projectstartups.com/lutrispharmalutrispharma.com04022025/"
---